Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sotagliflozin vs placebo in Chinese patients with Type 2 diabetes mellitus inadequately controlled by metformin +/- sulfonylurea; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED